glp 1 agonist drugs list GLP-1 Agonists Explained: Definition, How They Work, Side Effects List of GLP-1 Receptor Agonists

GLP-1 RAs have been shown to result in increased residual gastric contents (RGCs) in patients undergoing EGDs and poor Boston Bowel Preparation Scores (BBPSs) in those undergoing colonoscopies

Purpose of Review The development of long-acting incretin receptor agonists represents a significant advance in the fight against the concurrent epidemics of type 2 diabetes mellitus (T2DM) and obesity

Specifically, the trial reported an average weight loss of 17.5% and 24.4% at 24 and 48 weeks, respectively

Incretin based therapies with glucagon-like peptide-1 receptor agonists (GLP-1RA) are already established in the treatment of type 2 diabetes

- **Slow digestion:** Delaying stomach emptying to prevent spikes in sugar levels after meals